Skip to main content

VASO Corp

corporate_fare Company Profile

VASO Corp

VASO·OTC·Industrial Applications And Services·CIK 0000839087

Vaso Corporation operates in the healthcare equipment and information technology sectors in the United States and internationally. The company is structured into three segments: IT, Professional Sales Service, and Equipment. The IT segment specializes in healthcare information technology and managed network technology services, providing managed network infrastructure (including routers, switches, and other core equipment), managed network transport, and managed network security services. The Professional Sales Service segment focuses on selling healthcare capital equipment for General Electric Healthcare, Inc. (GEHC) to the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and financial services from GEHC and third parties. The Equipment segment designs, manufactures, sells, and services proprietary medical devices and software. This includes Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, which encompasses cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

VASO Corp (OTC:VASO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for VASO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 7/10. Across its 11 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for VASO spans 10-Q, 8-K, SCHEDULE 13D, 10-K.

Recent high-impact activity:

  • VASO Corp Q2 2026: Net Income $544K, NetWolves Sale Finalized
  • Vaso Swings to Q2 Profit as Revenue Climbs 8.3% to $11.2M
  • VASO Corp Divests NetWolves Subsidiary for $14.5M in Cash
  • VASO Corp Reports Narrowed Q1 Loss Amidst Critical Cash Burn and 37% Drop in Reserves
  • Vaso Corp Narrows Q1 Net Loss to $887K; Revenue Flat, Adjusted for Divestiture

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$89.1M
Net Income
$1.57M
Diluted EPS
$0.01
Op. Cash Flow
$9.27M
Gross Profit
$54.67M
Operating Income
-$2.89M
Cash & Equivalents
$35.05M
Debt / Equity
0.00×
Net Margin
1.8%
Shares Outstanding
175.95M sh
Source: 10-K · filed 2026-03-31 · accession 0001213900-26-037664

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 57,877 shares in VASO as of the September 15, 2026 settlement, a 41.1% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 1, 2026, 34.0% of VASO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)57,877 shares as of September 15, 2026
Change vs prior period▲ 41.1%
Days to cover1.00 at avg daily volume of 324,377
Daily short volume (FINRA facilities)34.0% of 5,852 shares on October 1, 2026
5-day average short volume21.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with V →
$0.2999 +0.01% today
52-week range · as of 2026-08-14 $0.105 – $0.2999
Market cap
$52.79M
Volume
28.3K (0.2× avg)
3-mo avg 132.6K
Live data · 2026-10-05 02:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed VASO - Latest Insights

VASO
Aug 14, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.268
Real-time Price: $0.2999 info
Change: +$0.0319 (+12%) info
Market Cap: $52.788M info
VASO
Aug 14, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.260
Real-time Price: $0.2999 info
Change: +$0.0399 (+15%) info
Market Cap: $52.788M info
VASO
Jul 31, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.1899
Real-time Price: $0.2999 info
Change: +$0.110 (+58%) info
Market Cap: $52.788M info
VASO
May 15, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.2312
Real-time Price: $0.2999 info
Change: +$0.0687 (+30%) info
Market Cap: $52.788M info
VASO
May 15, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.18855
Real-time Price: $0.2999 info
Change: +$0.11135 (+59%) info
Market Cap: $52.788M info
VASO
May 08, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.17983
Real-time Price: $0.2999 info
Change: +$0.12007 (+67%) info
Market Cap: $52.788M info
VASO
Apr 16, 2026, 9:03 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $0.1664
Real-time Price: $0.2999 info
Change: +$0.1335 (+80%) info
Market Cap: $52.788M info
VASO
Apr 10, 2026, 9:29 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $0.1648
Real-time Price: $0.2999 info
Change: +$0.1351 (+82%) info
Market Cap: $52.788M info
VASO
Mar 31, 2026, 5:25 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $0.1699
Real-time Price: $0.2999 info
Change: +$0.130 (+77%) info
Market Cap: $52.788M info
VASO
Mar 31, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.16658
Real-time Price: $0.2999 info
Change: +$0.13332 (+80%) info
Market Cap: $52.788M info
VASO
Feb 12, 2026, 3:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1765
Real-time Price: $0.2999 info
Change: +$0.1234 (+70%) info
Market Cap: $52.788M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets